CTOs on the Move


 
At Vyaire, we know that each patient has different goals—and every breath counts to achieve them. We are a company on the move, relentlessly innovating, challenging the status quo and keeping patient needs at the forefront of everything we do to enable, enhance and extend lives. Established from legacy brands with a 65-year history of pioneering breathing technology, Vyaire Medical Inc. is a global company focused exclusively on supporting breathing through every stage of life. We pledge to evolve what`s possible to ensure every breath is taken to its fullest. We accomplish this through our values: One Voice, Patient Purpose, ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.vyaire.com
  • 26125 North Riverwoods Boulevard
    Mettawa, IL USA 60045
  • Phone: 833.327.3284

Executives

Name Title Contact Details
Edward Rybicki
Global Chief Information Officer Profile

Similar Companies

Mainstay Medical

Mainstay is a medical device company focused on commercializing an innovative implantable restorative neurostimulation system, ReActiv8®, for people with disabling Chronic Low Back Pain (CLBP).

Healthcare Logistics

Healthcare Logistics is a Circleville, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Activation Laboratories

Activation Laboratories Ltd. is a Ancaster, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OXiGENE

OXiGENE is a biopharmaceutical company developing new and improved therapeutics that have the potential to deliver significant medical benefits to patients with cancer and serious medical conditions. Our primary focus is developing first-in-class anti-vascular drugs referred to as vascular disrupting agents (VDAs). Our lead compound in clinical development is fosbretabulin. VDAs are a new and highly differentiated class of anti-vascular drug that target existing tumor vasculature, leading to extensive tumor cell death. VDAs target the tumor vasculature rather than the tumor cells and therefore have broad potential therapeutic utility in cancer. Because VDAs act differently than anti-angiogenic drugs or cytotoxic chemotherapy drugs, VDAs are potentially complementary with anti-angiogenic drugs and chemotherapeutic agents. OXiGENE has ongoing VDA drug development programs and is committed to advancing the science of VDAs and their potential as innovative therapies to address unmet medical needs.

Msssie Research Labs

Msssie Research Labs is a Dublin, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.